Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study

Creative Commons License

Turan G. A., Eskicioglu F., Sivrikoz O. N., Cengiz H., Adakan S., Gur E. B., ...More

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.292, no.5, pp.1163-1171, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 292 Issue: 5
  • Publication Date: 2015
  • Doi Number: 10.1007/s00404-015-3747-5
  • Journal Name: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1163-1171
  • Keywords: Ovarian hyperstimulation syndrome, Pigment epithelium-derived factor, Vascular endothelial growth factor, Metformin, Myo-inositol, EPITHELIUM-DERIVED FACTOR, METFORMIN, OVULATION, DECREASES, INOSITOL, OUTCOMES, THERAPY, WOMEN
  • Dokuz Eylül University Affiliated: Yes

Abstract

Purpose To evaluate the efficacy of myo-inositol (MI) pretreatment in OHSS.